This Amedeo Smart survey is supported by Pfizer Oncology.
AmedeoCervical Cancer |
- PAIVA SANTOS J, Prata R, Serrado MA, Cunha TM, et al
Evaluating lymph node metastases in cervical cancer: the added value of T2/DWI MRI fusion compared to standard MRI alone and 18 F-FDG PET/CT.
Abdom Radiol (NY). 2026 Mar 9. doi: 10.1007/s00261-026-05415.
>> Share - REN W, Cui Z, Wu S, Shen F, et al
A Clinical-DKI Fusion Model for Objective Pretreatment Prediction of Parametrial Invasion in Cervical Cancer.
Acad Radiol. 2026 Mar 2:S1076-6332(26)00108-X. doi: 10.1016/j.acra.2026.
>> Share - MARTINS TR, Witkin SS, de Oliveira RL, Gadelha JGS, et al
EVALUATION AND RECOMMENDATIONS TO MODERNIZE CERVICAL CANCER DETECTION AND PREVENTION PROGRAMS IN BRAZIL: CHALLENGES AND OPPORTUNITIES - A NARRATIVE REVIEW.
Acta Cytol. 2026 Mar 9:1-20. doi: 10.1159/000550725.
>> Share - BOUBLENZA L, Nahet A, Masdoua N, Sadouki N, et al
Prevalence of human papillomavirus infection among women at a gynaecological clinic in Tlemcen, Algeria.
Afr J Reprod Health. 2023;27:56-63.
>> Share - ZHAO J, Liu X, Gao J, Xiao H, et al
Factors Associated with Lesion Recurrence Following Cervical Conization.
Altern Ther Health Med. 2023;29:50-55.
>> Share - TANG X, Peng X, Zhang W, Li Z, et al
Ultrasensitive Electrochemiluminescence Nanoprobe for Early Screening and Early Diagnosis of Cervical Cancer.
Anal Chem. 2026 Mar 11. doi: 10.1021/acs.analchem.5c08162.
>> Share - MASUMOTO S, Tanaka M, Yamamoto K, Hori Y, et al
HPV18-positive Small Cell Neuroendocrine Carcinoma of the Uterine Cervix Treated With Immunotherapy: A Case Report.
Anticancer Res. 2026;46:1733-1739.
>> Share
- SAILLANT A, Rasclard M, Gaume JB, Souchaud O, et al
A Case of Anti-3-hydroxy-3-methylglutaryl-coenzyme A Reductase Myopathy Associated With Advanced Cervical Carcinoma.
Anticancer Res. 2023;43:4723-4727.
>> Share - HUANG B, Lou Y, Zeng Z, Kan X, et al
A Cas12a-based fluorescent microfluidic system for rapid on-site human papillomavirus diagnostics.
Appl Microbiol Biotechnol. 2023;107:6287-6297.
>> Share - SUSHMA N, C R TP, Y S N, Kaginelli S, et al
Analysis of In-Vivo Dose Measurement of Urethra Using Array MOSFET Detectors and TPS-Calculated Dose in High-Dose-Rate Interstitial Brachytherapy in Gynaecological Malignancies.
Asian Pac J Cancer Prev. 2026;27:1091-1098.
>> Share
- SRIVASTAVA H, Raghuvanshi S, Bhalla S, Raghuvanshi S, et al
PIK3CA Polymorphisms in Cervical Cancer: Differential Impact of rs6443624 and rs141178472.
Asian Pac J Cancer Prev. 2026;27:1061-1068.
>> Share
- FATIHA RA, Ngabdi CK, Azizah JS, Putri BSN, et al
Disruption of EMT Signaling and Migration by Moringa oleifera Leaf Powder-Silver Nanoparticles (MOLP-AgNPs) in HeLa Cervical Cancer Cells.
Asian Pac J Cancer Prev. 2026;27:981-988.
>> Share
- MOSAVI JARRAHI A, Rajaie S, Azari S, Karimi F, et al
Standardizing Cost-Effectiveness Evidence for Cancer Prevention: A Case Study Analysis of HPV Vaccination.
Asian Pac J Cancer Prev. 2026;27:789-792.
>> Share - AZIZAH JS, Ngabdi CK, Fatiha RA, To SW, et al
Physicochemical characterization and anticancer potential of Ficus deltoidea-silver nanoparticles (FD-AgNPs) on HeLa cells: Evidence from apoptosis and proliferation assays.
Biochem Biophys Res Commun. 2026;808:153407.
>> Share - JI LY, Wang X, Jiao RX, Yang J, et al
Application of Cytokines in Cervical Secretion for High-grade Squamous Intraepithelial Lesion Caused by High-risk Human Papillomavirus Infection.
Biomed Environ Sci. 2026;39:215-222.
>> Share - ZHANG X, Yin Y, Yang T, Cong Y, et al
HALP outperforms systemic inflammatory biomarkers for prognosis in locally advanced cervical cancer treated with concurrent chemoradiotherapy.
Biomol Biomed. 2026 Mar 10. doi: 10.17305/bb.2026.13993.
>> Share - CUI YM, Shan YM, Xiao YY, Gao Y, et al
Analysis of prognosis in early-stage cervical cancer patients post-conization treated with laparoscopic versus open radical hysterectomy.
BMC Cancer. 2026 Mar 10. doi: 10.1186/s12885-026-15756.
>> Share
- OUMA GE, Asaso Omwodo K, Itsura P, Poli PA, et al
Characterizing trimodal therapy outcomes by HIV status in early-stage cervical cancer: a retrospective cohort study from a Kenyan tertiary center.
BMC Cancer. 2026 Mar 9. doi: 10.1186/s12885-026-15761.
>> Share
- WU M, Jiang Z, Xian X, Lu M, et al
Transrectal ultrasound-guided optimization of needle insertion for interstitial brachytherapy in the treatment of vaginal stump recurrence of cervical cancer.
BMC Cancer. 2026 Mar 7. doi: 10.1186/s12885-026-15819.
>> Share
- CHEN X, Li J, Sun Y, Ye Z, et al
LncRNA EGFR-AS1 inhibits ferroptosis to reduce radiosensitivity of cervical cancer through the m6A/IGF2BP3/APAF1 axis.
BMC Cancer. 2026 Mar 5. doi: 10.1186/s12885-026-15596.
>> Share
- ABERA GB, Alemayehu M, Sori DA, Ali R, et al
Time to death and its determinants among cervical cancer patients in Tigray, Ethiopia: a retrospective follow up study.
BMC Cancer. 2026 Mar 2. doi: 10.1186/s12885-026-15712.
>> Share - MENGISTIE MB, Ayalew WL, Mengistie SK, Gebeyehu AS, et al
Prevalence of cervical cancer and its associated factors among women living with HIV attending public referral hospitals in Amhara Region, Ethiopia, 2025, a cross-sectional study.
BMC Infect Dis. 2026 Feb 28. doi: 10.1186/s12879-026-12976.
>> Share - KIVUTI-BITOK LW, Mugo CW, Mituki D, Marete C, et al
The effect of school-based educational session on knowledge, attitudes, and beliefs of cervical cancer among adolescents in mixed day high schools in Embu County: a quasi-experimental study.
BMC Public Health. 2026 Mar 11. doi: 10.1186/s12889-026-26675.
>> Share - LEONARDSEN AL, Englund E, Trope A, Stensrud M, et al
The effect of a cervical testing campaign on incarcerated females- a repeated cross-sectional study in Norwegian prisons.
BMC Womens Health. 2026;26:141.
>> Share
- LI P, Wang H
The diagnostic value of colposcopy in postmenopausal women: a retrospective study.
BMC Womens Health. 2026;26:140.
>> Share - WILLIAMS HR, Kelly D
Prevention and Diagnosis of Cervical Cancers in the UK and Europe: What Have We Learned in the Last 10 Years and What Is Next?
Br J Hosp Med (Lond). 2026;87:50727.
>> Share - PAUTIER P, Genestie C, Gladieff L, Kurtz JE, et al
[Not Available].
Bull Cancer. 2023;110.
>> Share - HAN K
Advancing molecular residual disease detection in cervical cancer through next-generation sequencing of circulating human papillomavirus DNA.
Cancer. 2026;132:e70352.
>> Share - ZHANG L, Quan R, Huang H, Wu M, et al
Boronophenylalanine-Mediated Boron Neutron Capture Therapy Confers Selective Killing of Cervical Cancer by Exploiting DNA Repair Deficiency.
Cancer Biother Radiopharm. 2026 Mar 12:10849785261426657.
>> Share -
Corrigendum to "Prevalence of Human Papillomavirus Subtypes and Related Cytology in Estonian Cervical Cancer Screening Population in 2021".
Cancer Control. 2026;33:10732748261431083.
>> Share
- GAO H, Gao Q, Xue L, Lin H, et al
Risk Stratification for Underlying Cervical Intraepithelial Neoplasia Grade (CIN)3+ in Reproductive-Age Women With Biopsy-Confirmed CIN2: Implications for Fertility-Preserving Management.
Cancer Control. 2026;33:10732748261427836.
>> Share
- SSETAALA A, Muwonge I, Namulwa D, Kyakuwa N, et al
Cervical Cancer Screening in Uganda: Determinants of Past Screening and Post-Education Uptake; A Cross-Sectional Survey.
Cancer Control. 2026;33:10732748261427062.
>> Share - XUE L, Hao S, Sun H, Du L, et al
Spatial clustering of gynecological cancers in China: A countrywide migration-adjusted analysis at the district level.
Cancer Epidemiol. 2026;101:103023.
>> Share
- ZHANG C, Li X, Zhong L, Wang Y, et al
Assessment of the relationships between invasive endocervical adenocarcinoma and human papillomavirus infection and distribution characteristics in China: According to the new WHO classification criteria in 2020.
Cancer Epidemiol. 2023;86:102442.
>> Share
Cancer Epidemiol Biomarkers Prev - ISAACSON S, Spees LP, Hudgens MG, Pence BW, et al
Racial differences in expected versus actual costs of cervical cancer screening among low-income, under-screened women in North Carolina.
Cancer Epidemiol Biomarkers Prev. 2026 Mar 2. doi: 10.1158/1055-9965.EPI-25-0885
>> Share - KONG W, Liu P, Zhang J, Liu Q, et al
Chemoradiotherapy facilitates siglec-10(+)/siglec-9(+) macrophage-mediated impairment of CD24(+)/MUC16(+) tumor cell elimination and enhances PD-L2 dependent immunosuppression in cervical cancer.
Cancer Immunol Immunother. 2026;75:97.
>> Share - HUANG J, Li X, Zhuang Y, Zhang Z, et al
Nomogram Prediction Model and Prognostic Comparison of Cervical Clear Cell Carcinoma and Cervical Endometrioid Adenocarcinoma: A SEER Database Study.
Cancer Med. 2026;15:e71699.
>> Share
- JIA M, Zeng S, Zou J, Chen H, et al
Predicting Risk of Lymph Node Metastasis in Neuroendocrine Carcinoma of Cervix: A Validated Nomogram Incorporating Neuroendocrine Markers and Clinical Parameters.
Cancer Med. 2026;15:e71686.
>> Share
- ULMER KK, Sargent MD, Cina KR, Vinson AH, et al
Native American Women's Willingness to Screen for Both Cervical and Colorectal Cancer at Home.
Cancer Med. 2026;15:e71654.
>> Share
- KOTIAN N, Reddy Y, Pai P, Sundara BK, et al
A Critical Analysis of the Impact of Etoposide as a Topoisomerase II Inhibitor in Cervical Cancer Treatment: A Review.
Cancer Med. 2026;15:e71482.
>> Share - CAKIR Z, Gok Ugur H
The Effect of Motivational Interviewing Based on the COM-B Model on Women's Cervical Cancer Health Beliefs and Participation in Screening: A Single-Blind Randomized Controlled Trial.
Cancer Nurs. 2026 Mar 10. doi: 10.1097/NCC.0000000000001553.
>> Share
- BAHARVAND S, Asghari-Jafarabadi M, Nourizadeh R, Sattarzadeh Jahdi N, et al
The Effect of Decision Aid on Satisfaction With Decision and Anxiety Among Women With Abnormal Cervical Screening Results.
Cancer Nurs. 2023;46:E405-E411.
>> Share - WANG Z, Zhuang L, Liu S, Cao C, et al
Single-Cell and Multiomic Analysis Reveals Neutrophil Heterogeneity and Prognostic Value in Cervical Lesions.
Cancer Sci. 2026;117:597-612.
>> Share - ZHANG Y, Gao Y, Guan X, Wang E, et al
LILRB4 shapes an immunosuppressive microenvironment to drive cervical cancer progression through tumor-infiltrating myeloid cell expansion and CD8(+) T-cell suppression.
Cell Mol Life Sci. 2026;83:146.
>> Share - LI C, Zhao H, Wang J, Liu C, et al
A tumor-resident bacterium promotes cervical cancer progression through lysoPC-mediated c-Jun/c-Fos activation.
Cell Rep. 2026;45:117079.
>> Share - SANCHEZ DIAZ E, Levin G, Fernandes A, Fletcher A, et al
Clinical evidence on a Coriolus versicolor-based vaginal gel for HPV-related cervical disease: a narrative review.
Chin Clin Oncol. 2026;15:9.
>> Share - YIN L, Zhang J, Pang Y, Mou Y, et al
Predictive value of R2 * values derived from blood oxygen level-dependent magnetic resonance imaging for lymph node metastasis after neoadjuvant chemotherapy for cervical squamous cell carcinoma.
Clin Radiol. 2026;94:107149.
>> Share - VAN KEER S, van den Helder R, Teblick L, De Smet A, et al
Clinical performance of ASCL1/LHX8 DNA methylation on first-void urine to screen for cervical cancer.
Commun Med (Lond). 2026 Mar 12. doi: 10.1038/s43856-026-01512.
>> Share - RASHEED A, Shirazi SH, Khan P, Aseere AM, et al
cervical nuclei segmentation through synergic conditional generative adversarial network in cervical smear images.
Comput Biol Chem. 2026;122:108918.
>> Share - BODHARE T, Bele S, V S, Sheela Kumari K S, et al
An Intervention Study Assessing the Effects of a Breast and Cervical Cancer Health Education Program on Knowledge, Attitudes, and Practices Among Adolescent Female Students in Madurai, South India.
Cureus. 2026;18:e103131.
>> Share
- ACHARYA GC, Das S, Jasuja A, Debata I, et al
Perception, Practices, and Barriers to Cervical Cancer Screening Among Women in Rural and Urban Slums of Eastern India: A Community-Based Cross-Sectional Study.
Cureus. 2026;18:e102449.
>> Share - EL-MOGASSABI A, Baiu HS, Hassan NO, Salem EM, et al
Translation, adaptation and validation of the AWACAN tool for breast and cervical cancer awareness among Arabic-speaking women: a study from Libya.
Ecancermedicalscience. 2025;19:2047.
>> Share
- PUENTE-VALLEJO R, Garcia-Gutierrez A, Jara-Jimenez S, Mosquera-Ruiz MN, et al
Impact of treatment delay on survival in women diagnosed with cervical cancer in Quito, Ecuador: a retrospective cohort study.
Ecancermedicalscience. 2025;19:2039.
>> Share
- DAS NEVES MAB, Galvao ND, de Lima FCDS, Oliveria JFP, et al
Factors associated with advanced diagnosis of cervical cancer: a hospital-based retrospective study in a state of the Brazilian Legal Amazon.
Ecancermedicalscience. 2025;19:2045.
>> Share - VALENZA C, Spada F, Multinu F, Benini L, et al
Multimodal treatment for resectable neuroendocrine carcinoma of the cervix.
Endocr Relat Cancer. 2023;30:e230112.
>> Share - RYU SY, Nam BH, Kim MH, Jang WI, et al
A randomized phase III clinical trial of weekly versus tri-weekly cisplatin-based chemoradiotherapy for locally advanced cervical cancer: results of the TACO (GCIG/KGOG 1027/THAI 2012) study.
ESMO Open. 2026;11:106102.
>> Share - ZHANG G, Zhang X, Li H, Du X, et al
Multi-omic and immune landscapes of HPV-negative versus HPV-positive cervical cancer reveal implications for immunotherapy.
Eur J Surg Oncol. 2026;52:111425.
>> Share - VILLANUEVA-AGUILAR ME, Rizo-de la Torre LC, Bencomo-Alvarez AE, Gallegos-Arreola MP, et al
Sequence analysis of exons 30 and 31 of LAMA3 gene variants and its association with human papillomavirus infection predisposition: no evidence was found.
Eur Rev Med Pharmacol Sci. 2023;27:6860-6866.
>> Share
- ALHARBI SA, Alshammari FD, Humaida MI, Abdalhabib EK, et al
The cytological pattern of cervical smears of a series of Saudi women in one gynecologic center.
Eur Rev Med Pharmacol Sci. 2023;27:6785-6791.
>> Share - SVINTSITSKY V, Yegorov M, Stakhovsky E, Vitruk Y, et al
NON-STANDARD STRATEGIES IN THE TREATMENT OF ADVANCED CERVICAL CANCER: A CASE SERIES.
Exp Oncol. 2026;47:467-477.
>> Share - ZHOU J, Ye W, Ranarisoa SN, Tian L, et al
Comparison of drug regimens for recurrent or metastatic cervical cancer: a systematic review and network meta-analysis.
Front Immunol. 2026;17:1775409.
>> Share
- ZHOU G, Chen W, Dong X, Guo Q, et al
Nocardia rubra cell wall skeleton-induced MARCO expression: implications for improved phagocytosis and cytokine secretion in tumor-associated macrophages.
Front Immunol. 2026;17:1611476.
>> Share
- ZELINI P, Zavaglio F, Dominioni M, Valsecchi M, et al
Detection of human papillomavirus (HPV)-specific T cell response in women with low-grade cervical intraepithelial lesion and HPV vaccinated subjects.
Front Immunol. 2026;16:1733404.
>> Share - LI G, Lu Z, Yin F, Lu H, et al
High-risk HPV and bacterial STIs in a primary screening population in rural Hainan, China: prevalence, co-infection, and association with cervical abnormalities.
Front Public Health. 2026;14:1773020.
>> Share - BERHANU W, Yigremachew S, Hanson C, Avermark H, et al
A missed opportunity: faith leaders and the HPV vaccination effort in Addis Ababa, Ethiopia.
Glob Health Action. 2026;19:2635822.
>> Share - MOREL D, Parvu V, Andrews J, Stephenson P, et al
HPV genotype prevalence in low- and high-vaccine coverage, USA populations: Data from real-world cervical cancer screening using the Onclarity HPV assay.
Gynecol Oncol. 2026;207:40-47.
>> Share
- SAAB RH, Salvo G, Gonzales NR, Munsell MF, et al
Social media use is associated with higher levels of anxiety and depression in patients with neuroendocrine carcinoma of the cervix: A NeCTuR study.
Gynecol Oncol. 2023;177:95-102.
>> Share - TAWE L
Mapping the HPV Detection Landscape in Botswana: A Narrative Review of Diagnostic Platforms and Their Impact on Cervical Cancer Control.
Health Sci Rep. 2026;9:e72038.
>> Share
- KYEI-ARTHUR F, Agyekum MW, Afrifa-Anane GF, Alhassan N, et al
Cervical Cancer Screening Prevalence and Predictors Among Women Aged 25-49 Years in Ghana: A Cross-Sectional Study.
Health Sci Rep. 2026;9:e71971.
>> Share - MATHOBELA MN, Chuang TW, Chen PC, Motsa MPS, et al
Prevalence and factors associated with urinary schistosomiasis in women attending cervical cancer screening in Sithobela, Eswatini: A facility-based cross-sectional study.
Helminthologia. 2025;62:296-303.
>> Share - ZHAO J, Wang L, Shao N, Qu Y, et al
RRM2/GCH1 signaling decreased cisplatin sensitivity in cervical cancer by modulating the ferroptosis process.
Histol Histopathol. 2026 Mar 6:25056. doi: 10.14670.
>> Share - LEE YS, Yim K, Kim CJ, Kim JH, et al
Tumour budding in pretreatment cervical biopsies: a prognosticator for personalised therapy in the era of precision oncology.
Histopathology. 2026;88:970-984.
>> Share
- YASUTAKE N, Yokawa Y, Tanaka T, Mishima R, et al
Claudin-18 expression in gastric type adenocarcinoma and HPV-associated adenocarcinoma of the uterine cervix.
Histopathology. 2026;88:1003-1015.
>> Share - ZHANG Z, Quddus MR, Sung CJ, Singh K, et al
Morphologic and immunohistochemical study of HPV-related cervical adenosquamous carcinoma: Reappraisal of a poorly defined entity.
Hum Pathol. 2026;170:106052.
>> Share - JIANG L, Ma S, Du Q, Lv J, et al
Prognostic value of Node-RADS scoring in stage IIICr cervical cancer: development and validation of novel nomograms.
Insights Imaging. 2026;17:64.
>> Share - ZHANG H, Liu C, Zhai X, Zhang Q, et al
Disfunction of communication among immune cells in minimal-deviation adenocarcinoma of the cervix as an immunotherapeutic opportunity.
Int Immunopharmacol. 2023;124.
>> Share - KARRBERG C, Gray P, Elfgren K, Milerad H, et al
Nationwide audit of cervical cancer screening reveals unsatisfactory triage strategies and trends over time in incidence among cytology negative women.
Int J Cancer. 2026 Mar 9. doi: 10.1002/ijc.70415.
>> Share
- LEHTINEN M, Lipsitch M, Pimenoff VN, Sundstrom K, et al
Predicting optimal impact interventions in the post-HPV vaccination world.
Int J Cancer. 2026 Jan 19. doi: 10.1002/ijc.70297.
>> Share
- TSEGAYE AT, Mashele SA, Shing JZ, Mwansa-Kambafwile J, et al
Race-specific temporal trends of HPV-related cancers in South Africa: An analysis of the South African National Cancer Registry, 2011-2022.
Int J Cancer. 2025 Dec 31. doi: 10.1002/ijc.70323.
>> Share
- LEI J, Falcaro M, Brentnall AR, O'Mahony JF, et al
Indicators to identify cancer screening providers with suboptimal case detection: A scoping review.
Int J Cancer. 2026;158:2339-2358.
>> Share - IWAHASHI N, Noguchi T, Sakai K, Yahata T, et al
Comprehensive circulating tumor DNA mutation profiling via CAPP-Seq liquid biopsy for cervical cancer.
Int J Clin Oncol. 2026 Mar 10. doi: 10.1007/s10147-026-03006.
>> Share - ZULFIKAROGLU E
Cervical cancer screening strategies in women 65 years and older in the human papillomavirus era: A systematic review and meta-analysis of human papillomavirus-based testing and self-sampling approaches.
Int J Gynaecol Obstet. 2026 Mar 12. doi: 10.1002/ijgo.70962.
>> Share - ZHOU J, Cai J, Li X, Liu C, et al
Correspondence on "Pelvic radiotherapy combined with immunotherapy and chemotherapy for stage IVB cervical cancer: a retrospective study".
Int J Gynecol Cancer. 2026 Feb 11:104551. doi: 10.1016/j.ijgc.2026.104551.
>> Share
- SANTIA MC, Morante-Caicedo C, Pineros Castillo WA, Taylor A, et al
Surgical de-escalation of cervical cancer treatment in limited-resource settings.
Int J Gynecol Cancer. 2026 Mar 2:102862. doi: 10.1016/j.ijgc.2025.102862.
>> Share
- VIVEROS-CARRENO D, Agusti N, Mora-Soto N, Wilke RN, et al
De-escalation in definitive surgical management for cervical cancer.
Int J Gynecol Cancer. 2025 Oct 9:102711. doi: 10.1016/j.ijgc.2025.102711.
>> Share
- CAICEDO-MARTINEZ M, Arbelaez-Marino AF, Arbelaez L, Farach A, et al
Refinement in radiotherapy treatment for locally advanced cervical cancer: a historic perspective.
Int J Gynecol Cancer. 2026 Mar 2:102878. doi: 10.1016/j.ijgc.2025.102878.
>> Share
- MORA-SOTO N, Viveros-Carreno D, Morante-Caicedo C, Pineros W, et al
Neoadjuvant chemotherapy in cervical cancer: a narrative review.
Int J Gynecol Cancer. 2026 Mar 2:102827. doi: 10.1016/j.ijgc.2025.102827.
>> Share - GUO Y, Li S, Liu T, Chang X, et al
Gene Mutations and Related Molecular Events in Distant Metastasis of Cervical Cancer: A Review.
Int J Med Sci. 2026;23:1015-1032.
>> Share - KIM A, Kim J, Kwak W, Mo K, et al
Therapeutic implications of targeting cancer testis antigen MAGEA1 in cervical cancer.
Int J Oncol. 2026;68:57.
>> Share - KAYALI E, Comert GK, Yildirim HT, Toptas T, et al
Nicotinamide Phosphoribosyltransferase (NAMPT) as a New Marker in Cervical Preinvasive Lesions.
Int J Surg Pathol. 2026;34:385-391.
>> Share - PAN G, Wang W, Sun Z, Chu R, et al
High-Risk Clinical Characteristics and Risk Model for Unexpected Cervical Cancer Diagnosed After Surgery in Patients with LSIL/HSIL Biopsy.
Int J Womens Health. 2026;18:584455.
>> Share - ZHANG J, Zhang Y, Zhang J
BATF Drives Cervical Cancer Progression and Immune Evasion by Regulating the STAT1-PD-L1 Axis.
Iran J Immunol. 2026;23.
>> Share - CHENG Y, Wang J, Wang L, Yan D, et al
Systemic immune-inflammatory index for the prediction of the survival in patients with cervical cancer: A meta-analysis.
iScience. 2026;29:114862.
>> Share - WANG J, Zhang Y, Wang H, Zhang J, et al
Cystathionine-gamma-Lyase/Hydrogen Sulfide Axis Plays a Crucial Role in Promoting the Progression of Cervical Cancer.
J Biochem Mol Toxicol. 2026;40:e70765.
>> Share - SUROV A, Hohn AK, Hinnerichs M, Meyer HJ, et al
Associations Between Body Composition and Intratumoural Immune Cells in Patients With Uterine Cervical Cancer.
J Cachexia Sarcopenia Muscle. 2026;17:e70241.
>> Share - JUNIOR DST
Incorporation of HPV-DNA molecular test into the Brazilian healthcare system.
J Cancer Policy. 2026;47:100713.
>> Share
- AZIM MR, Sakib QN, Rahman MM, Islam MS, et al
Economic burden of breast, cervical, and oral cancer in Bangladesh: a cost-of-illness study.
J Cancer Policy. 2026;47:100694.
>> Share
- GAO T, Farag M, Agha S, Mobula L, et al
Economic evaluation of the one-dose HPV vaccination program in Nigeria.
J Cancer Policy. 2026;47:100675.
>> Share
- DORJI N, Dorji T, Dorjey Y, Yangdon Y, et al
Quality improvement initiatives on colposcopy and treatment of cervical pre-cancer services in Bhutan: Experiences, challenges, and way forward.
J Cancer Policy. 2026;47:100676.
>> Share - WANG X, Shi W, Pu X, Hu Y, et al
Development and validation of nomograms to recurrence and survival in patients with early-stage cervical adenocarcinoma.
J Cancer Res Clin Oncol. 2023;149:13727-13739.
>> Share
- THANGARAJAH F, Busshoff J, Salamon J, Pruss MS, et al
Digital droplet PCR-based quantification of ccfHPV-DNA as liquid biopsy in HPV-driven cervical and vulvar cancer.
J Cancer Res Clin Oncol. 2023;149:12597-12604.
>> Share - ZHANG J, Wang H, Liu Y, Li Z, et al
HPV testing with 16/18 genotyping for risk stratification among women with normal cytology: a multicenter prospective cohort study from China.
J Clin Microbiol. 2026 Feb 19:e0128925. doi: 10.1128/jcm.01289.
>> Share - MASSAD LS
Incremental Progress in the Cervical Cancer Screening Revolution.
J Clin Oncol. 2026 Mar 2:JCO2503021. doi: 10.1200/JCO-25-03021.
>> Share - NGHIEM VTH, Smith S, Shi J, McBrayer A, et al
Acceptability and Feasibility of Home-Based Human Papillomavirus Self-Testing as Primary Screening for Cervical Cancer Detection in the State of Alabama.
J Community Health. 2026 Mar 6. doi: 10.1007/s10900-026-01554.
>> Share - KONGWATTANAKUL S, Petroch P, Nimjaroen K, Bawornpatarapakorn S, et al
The effectiveness of a 3-dimensional printed vaginal dilator in mitigating radiation-induced vaginal stenosis for patients with cervical cancer.
J Gynecol Oncol. 2026 Feb 24. doi: 10.3802/jgo.2026.
>> Share
- LIN J, Wu Q, Liu B, He H, et al
Neoadjuvant therapy of iparomlimab and tuvonralimab combined with chemotherapy-extenuated for locally advanced cervical cancer (NICE-CC): an investigator-initiated, multicentre, open-label, phase II trial.
J Gynecol Oncol. 2026 Feb 9. doi: 10.3802/jgo.2026.
>> Share - HE J, Cheng C, Ding Y, Li N, et al
Design of Therapeutic Vaccines Based on Antigen Epitopes of alpha-9 HPV E6 in Sichuan.
J Immunother. 2026;49:87-97.
>> Share - YAN M, Yang Y, Zhao Y, Ma L, et al
Prevalence and genotype distribution of high-risk human papillomavirus infection among Chinese women aged 35-64: A national screening population-based study.
J Infect. 2026;92:106697.
>> Share - KIHARA K, Kajiyama Y, Kimura Y, Okazaki S, et al
Adult-onset botulism in a Japanese woman with prolonged spore excretion.
J Infect Chemother. 2023;29:1172-1176.
>> Share - CUI Y, Li Y, Na J, Lu J, et al
Investigating the causal association between plasma lipids and the risk of squamous cervical cancer: A two-sample mendelian randomization study.
J Med Biochem. 2025;44:1843-1849.
>> Share - MATOBA Y, Oomori Y, Nishibuchi I, Uegami S, et al
Reirradiation for Recurrent Cervical Cancer Within the Previous Radiation Field Using a Bioabsorbable Spacer: A Case Report.
J Obstet Gynaecol Res. 2026;52:e70225.
>> Share
- PENG Y, Wang L, Jin F, Su Z, et al
Application of Manual Lymph Drainage Combined With Complex Decongestive Therapy in Lower Limb Lymphedema After Cervical Cancer Surgery and Its Impact on Quality of Life.
J Obstet Gynaecol Res. 2026;52:e70217.
>> Share - KOVACEVIC IN, Jovanovic A, Ristic J, Milic N, et al
Effect of Organized Cervical Cancer Screening Programs on Incidence and Mortality: A Systematic Review and Meta-analysis.
J Prev (2022). 2026 Mar 4. doi: 10.1007/s10935-026-00908.
>> Share - NAVARRO-TORNE A, Aris E, Callegaro A, Benninghoff B, et al
Maximizing impact: the power of early HPV vaccination for long-term protection-lessons from a systematic review and meta-regression analysis.
J Public Health (Oxf). 2026;48:216-227.
>> Share
- NGUYEN-THANH H, Marshall L, Wilson H, Stewart K, et al
Awareness of HPV-related cancers and the HPV vaccination programme in Scotland: a cross-sectional study of gender, deprivation and knowledge gaps.
J Public Health (Oxf). 2026;48:239-248.
>> Share - LINDWALL G, Gerlee P
Bayesian inference on the Allee effect in cancer cell line populations using time-lapse microscopy images.
J Theor Biol. 2023;574:111624.
>> Share - WU H, Yu Y, Wang W, Xu Q, et al
SMC4/SMAD3/NF-kappaB axis drives cervical cancer progression and radioresistance via DNA damage repair and immune modulation.
J Transl Med. 2026 Mar 9. doi: 10.1186/s12967-026-07979.
>> Share - LIU X, Vidrine DJ, Sutton SK, Wetter DW, et al
Cost-Effectiveness of Smoking Cessation Among Survivors of Cervical Intraepithelial Neoplasia or Cervical Cancer.
JAMA Netw Open. 2026;9:e261543.
>> Share
- GOTTSCHLICH A, Smith LW, Hong Q, Dabee S, et al
HPV, Cytology, and Cotest Cervical Cancer Screening and the Risk of Precancer.
JAMA Netw Open. 2026;9:e261304.
>> Share - ANSARI SN, Kunwar R, Vaidya SA
Immunohistochemical Expression of P16 in Cervical Lesions: An Observational Study.
JNMA J Nepal Med Assoc. 2025;63:823-827.
>> Share - KIRUTHIGA N, Krishnan S, Arulsamy S, Natarajan A, et al
Design and Synthesis of Piperidine Hydroxamate Scaffolds as Novel HDAC Inhibitors with Apoptotic Potential in Human Cervical Cancer Cells.
Med Chem. 2026 Mar 2. doi: 10.2174/0115734064378681251128061500.
>> Share - CHEN X, Zheng X, Yang Z, Sui F, et al
Clinicopathologic characteristics and survival outcomes of patients with high-grade neuroendocrine cervical cancer.
Medicine (Baltimore). 2026;105:e47961.
>> Share
- LI Y, Zhang W, Tang L, Zhu Y, et al
Core targets of bisphenol A in cervical cancer revealed by network toxicology and molecular docking.
Medicine (Baltimore). 2026;105:e47993.
>> Share - TUSAR MTT, Ara R, Farazi R, Roy CR, et al
Complete genome sequence of human papillomavirus type 45 identified from a cervical cancer patient in Bangladesh.
Microbiol Resour Announc. 2026 Mar 10:e0138225. doi: 10.1128/mra.01382.
>> Share - STOUT CE, Poiani LTH, Mcglynn A, Enujioke CDRSC, et al
Recommendation for Human Papillomavirus Vaccine after Abnormal Pap Smear in Unvaccinated Active Duty Women.
Mil Med. 2026;191.
>> Share - ALI AA, McCrudden CM, McCaffrey J, McBride JW, et al
DNA vaccination for cervical cancer; a novel technology platform of RALA mediated gene delivery via polymeric microneedles.
Nanomedicine. 2026 Feb 27:102923. doi: 10.1016/j.nano.2026.102923.
>> Share - MAYUMI WADA C, Ferrari G, Silveira da Silva L, Pitton M, et al
Intrauterine devices incorporating nanocarriers for targeted cervical cancer therapy.
Nanomedicine (Lond). 2026 Mar 11:1-13. doi: 10.1080/17435889.2026.2641148.
>> Share - HASSINE A, Tisler A, Martel M, Bardou M, et al
Risk of cervical cancer and high-grade lesions in vulnerable women a systematic review and meta-analysis.
Nat Commun. 2026 Mar 2. doi: 10.1038/s41467-026-70050.
>> Share - NITTA N, Sugiyama Y, Sugimura T, Ito T, et al
Clinical-grade autonomous cytopathology through whole-slide edge tomography.
Nature. 2026;651:472-481.
>> Share - MADZARAC V, Culej D, Muzinic D, Zovko G, et al
Small-cell neuroendocrine carcinoma of the cervix associated with adenocarcinoma in situ: A case report with analysis of molecular abnormalities.
Neuro Endocrinol Lett. 2023;44:332-335.
>> Share - ZHANG H, Luo X, Jiang J, Zhang C, et al
The clinical application value of dynamic monitoring of HPV ctDNA in concurrent chemoradiotherapy for locally advanced cervical cancer.
NPJ Precis Oncol. 2026 Mar 3. doi: 10.1038/s41698-026-01348.
>> Share - YANG T, Tang M, Xu L, Jiang L, et al
A tailored phosphorothioate coordinator enables CRISPR/Cas in-situ amplification.
Nucleic Acids Res. 2026;54:gkag187.
>> Share - HUA Y, Li Y, Qin H, Huo M, et al
Association Between Folate Status and Risk of Cervical Cancer: A Systematic Review, Dose-Response Meta-analysis, and Mendelian Randomization Study.
Nutr Rev. 2026 Mar 11:nuag016. doi: 10.1093.
>> Share - KIM JH, Shim SH, Min KJ, Lee JK, et al
Consensus-based guideline of the Korean Society of Gynecologic Oncology for high-risk HPV testing in cervical cancer screening.
Obstet Gynecol Sci. 2026 Mar 4. doi: 10.5468/ogs.26066.
>> Share - LIN S, Ouyang Y, Gu H, Chen K, et al
Toward fully automated pre-implantation planning for cervical cancer brachytherapy: a template-guided multi-criteria optimization framework for catheter placement and dose distribution.
Phys Med Biol. 2026 Mar 11. doi: 10.1088/1361-6560.
>> Share - MITCHELL LE, Phillips E, Jennett CJ, Bavor C, et al
Experiences of HPV self-collection among Aboriginal and Torres Strait Islander women and people with a cervix.
PLoS One. 2026;21:e0326551.
>> Share
- HASBAY E, Sahin S, Kelten Talu EC, Sanci M, et al
MRI differentiation of usual type endocervical adenocarcinoma and cervical squamous cell carcinoma.
PLoS One. 2026;21:e0343764.
>> Share - ZHU Y, Liu K, Yang Z, Peng Z, et al
Machine-learning with multiomics for radiotherapy-induced acute rectal toxicities and survival outcome in patients with cervical cancer.
Radiat Oncol. 2026 Mar 5. doi: 10.1186/s13014-026-02814.
>> Share - MACKENZIE P, Vajdic C, Delaney G, Comans T, et al
Development of an age- and comorbidity- adjusted optimal radiotherapy utilisation rate for lung, rectal, prostate and cervical cancers.
Radiother Oncol. 2023;188:109862.
>> Share - ZI XJ, Li YL, Chu ZY
Mechanisms of bisphenols-induced cervical cancer: A multidimensional bioinformatics analysis.
Reprod Toxicol. 2026;141:109209.
>> Share - GONZALEZ GMN, Inam ME, Msadabwe S, Lee KL, et al
Social Determinants of Health Impact Cervical Cancer Stage at Presentation among Women in Zambia.
Res Sq [Preprint]. 2026 Feb 23:rs.3.rs-8522732. doi: 10.21203/rs.3.rs-8522732.
>> Share - ZHENG L, Zhao G, Zheng L, Zou Y, et al
Insights Into Highly Associated Co-Factors on HPV-Related Cervical Cancer.
Rev Med Virol. 2026;36:e70131.
>> Share
- MURAHWA AT, Dzobo M, Mahenge A, Rantshabeng P, et al
The Burden of HPV35 in African Cervical Pathologies: Prevalence, Contributing Factors, and Vaccine Prospects.
Rev Med Virol. 2026;36:e70129.
>> Share - BENCHEIKH S, Lemriss H, Souiri A, Akachar J, et al
Human papillomavirus-encoded microRNAs: key regulators in cervical cancer development.
RNA Biol. 2026;23:1-14.
>> Share - TRYBUS W, Trybus E, Krol T
Alizarin induces a multidirectional mechanism of anti-cancer action in cervical cancer and prostate cancer cells.
Sci Rep. 2026 Mar 10. doi: 10.1038/s41598-026-43011.
>> Share
- ALSULAYS BB, Anwer MK, Hatata MN, Raish M, et al
Development of beta-CD metal organic frameworks loaded with olaparib: a novel approach for the treatment of cervical cancer.
Sci Rep. 2026 Mar 10. doi: 10.1038/s41598-026-43779.
>> Share
- HU D, Zhao Y, Han M, Qian W, et al
Analysis of factors associated with cervical cancer and precancerous lesions.
Sci Rep. 2026 Mar 9. doi: 10.1038/s41598-025-32215.
>> Share
- ISLAM O, Assaduzzaman M, Akter S, Fahad N, et al
Enhanced cervical cancer diagnosis using a novel Bayesian fusion ensemble method with explainable AI.
Sci Rep. 2026 Mar 5. doi: 10.1038/s41598-026-35334.
>> Share
- MA X, Xu Z, Chen Y, Jiang F, et al
KIF20A promotes cervical cancer progression by interacting with CLIP1.
Sci Rep. 2026 Mar 3. doi: 10.1038/s41598-026-42883.
>> Share
- BI Y, Ye Y, Wu X, Cao H, et al
Mechanism of isoleucyl-tRNA synthetase 2 regulating proliferation and apoptosis of cervical cancer cells.
Sci Rep. 2026 Mar 2. doi: 10.1038/s41598-026-41218.
>> Share - FREIJOMIL-VAZQUEZ C, Gastaldo D
The Intersecting Effects of Biomedicine and Patriarchy on the Social Lives of Women Undergoing Cervical Cancer Prevention.
Semin Oncol Nurs. 2026 Feb 27:152173. doi: 10.1016/j.soncn.2026.152173.
>> Share - VEGA C, Leon R, Medina N, Fabelo H, et al
Design and Characterization of a Hyperspectral Colposcope Based on Dual-LCTF VNIR Narrow-Band Illumination.
Sensors (Basel). 2026;26:1255.
>> Share - CLAIRE LIN CC, Tai CC, Hung P, Tung YC, et al
Corrigendum to "Community mobile health clinics' availability is associated with cervical cancer screening in rural and urban areas: A national cohort study in Taiwan" [Taiwan J Obstet Gynecol 64 (2025) 1024-1029].
Taiwan J Obstet Gynecol. 2026;65:399.
>> Share
- ZHENG J
Comment on "Recent advances in cervical cancer treatment: Innovations from early-stage to advanced disease".
Taiwan J Obstet Gynecol. 2026;65:393.
>> Share
- WENG CS, Chen RC, Chen HJ, Tsay JY, et al
Genotype-specific prevalence of high-risk human papillomavirus among cytologically normal women in Taiwan.
Taiwan J Obstet Gynecol. 2026;65:292-298.
>> Share
- WANG CC, Liu SH, Wu MH, Chen JR, et al
Increased risk of ischemic stroke in cervical cancer patients received radiotherapy: A nationwide population-based study.
Taiwan J Obstet Gynecol. 2026;65:247-255.
>> Share - XIAO G, Quan K, Zeng M, Ye Y, et al
Region-specific Multi-Omics Modeling for Predicting Acute Radiation-Induced Proctitis in Cervical Cancer Radiotherapy: A Retrospective Analysis.
Technol Cancer Res Treat. 2026;25:15330338261424144.
>> Share - MIAO Z, Yang XL, Zhu JW, Zhou YC, et al
The differences of pelvic lymph node metastasis between squamous cell carcinoma and adenocarcinoma in early-stage cervical cancer patients undergoing radical surgery and adjuvant radiotherapy: a large cohort study.
Ther Adv Med Oncol. 2026;18:17588359261425694.
>> Share - LIANG H, Li Q, Liao Y, Huang H, et al
Rosa roxburghii Tratt fruit polysaccharides inhibit proliferation and induce apoptosis in human cervical cancer cell line.
Transl Cancer Res. 2026;15:121.
>> Share -
Prophylactic para-aortic irradiation vs pelvic radiotherapy in pelvic node-positive carcinoma cervix in the setting of concurrent chemoradiation: a phase II open-label multi centric randomized controlled trial (PRO-PARA).
Trials. 2026;27:195.
>> Share - SHADANG M, Arumugam A, Singh DK, Keshari P, et al
The R2TP complex stabilises E7 to drive human papillomavirus-mediated pathogenesis in cellular models of cervical cancer.
Virol J. 2026;23:66.
>> Share - POY M, Jacquot K, Gross S, Lepiller Q, et al
[Development and distribution of an inter-laboratory comparison test for HPV testing].
Virologie (Montrouge). 2026;30:63-69.
>> Share
- CHARPENTIER C, Brousseau J, Jary A, Ferre VM, et al
[Cervical cancer screening: what role for methylation tests?].
Virologie (Montrouge). 2026;30:19-32.
>> Share
- DOGHMAN I, Malassigne V, Roucaute L, Azais H, et al
[Advances in screening and follow-up of HPV-related cervical cancer].
Virologie (Montrouge). 2026;30:7-18.
>> Share - SAITO M, Rajesh A, Innes C, van der Griend R, et al
The High-Risk Human Papillomavirus Type Influences the Tissue Microenvironment in Cervical Intraepithelial Neoplasia Grade 2.
Viruses. 2023;15:1953.
>> Share
- CHAIWONGKOT A, Buranapraditkun S, Oranratanaphan S, Chuen-Im T, et al
Efficiency of CIN2+ Detection by Thyrotropin-Releasing Hormone (TRH) Site-Specific Methylation.
Viruses. 2023;15:1802.
>> Share - WILLIAMS DM, Reilly S, Lord T, Ayers K, et al
"Give me the sense that I matter:" Queer women's recommendations for an ideal cervical cancer screening exam and pathways to screening equity.
Womens Health (Lond). 2026;22:17455057261428108.
>> Share
- FASZHOLZ AM, Lozano V, Garda J
Structure, utilization, and screening adherence of a student-run women's health clinic for uninsured Spanish-speaking women: A descriptive analysis.
Womens Health (Lond). 2026;22:17455057261424823.
>> Share - ZOU Z, Huang L, Yin K, Li Y, et al
Effect of immune-related lncRNA BZRAP1-AS1/miR-541-3p and its molecular mechanism in cervical cancer.
World J Surg Oncol. 2026 Mar 9. doi: 10.1186/s12957-026-04270.
>> Share
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016
